<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" open-status="O" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cold Spring Harb Mol Case Stud</journal-id><journal-id journal-id-type="iso-abbrev">Cold Spring Harb Mol Case Stud</journal-id><journal-id journal-id-type="hwp">cshmcs</journal-id><journal-id journal-id-type="pmc">cshmcs</journal-id><journal-id journal-id-type="publisher-id">cshmcs</journal-id><journal-title-group><journal-title>Cold Spring Harbor Molecular Case Studies</journal-title></journal-title-group><issn pub-type="epub">2373-2873</issn><publisher><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5983172</article-id><article-id pub-id-type="doi">10.1101/mcs.a002410</article-id><article-id pub-id-type="medline">MCS002410Kob</article-id><article-categories><subj-group subj-group-type="heading"><subject>Rapid Communication</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="75775" pm="."><plain>A de novo nonsense mutation in ASXL3 shared by siblings with Bainbridge–Ropers syndrome </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="left-running"><italic>ASXL3</italic> mutation in Bainbridge–Ropers syndrome</alt-title><alt-title alt-title-type="right-running"><italic>ASXL3</italic> mutation in Bainbridge–Ropers syndrome</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Koboldt</surname><given-names>Daniel C.</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mihalic Mosher</surname><given-names>Theresa</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Kelly</surname><given-names>Benjamin J.</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sites</surname><given-names>Emily</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Bartholomew</surname><given-names>Dennis</given-names></name><xref ref-type="aff" rid="af2">2</xref><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hickey</surname><given-names>Scott E.</given-names></name><xref ref-type="aff" rid="af2">2</xref><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>McBride</surname><given-names>Kim</given-names></name><xref ref-type="aff" rid="af2">2</xref><xref ref-type="aff" rid="af3">3</xref><xref ref-type="aff" rid="af4">4</xref></contrib><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>Richard K.</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>White</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="aff" rid="af2">2</xref></contrib></contrib-group><aff id="af1"><label>1</label>Institute for Genomic Medicine at Nationwide Children's Hospital, Columbus, Ohio 43205, USA;</aff><aff id="af2"><label>2</label>Department of Pediatrics, The Ohio State University, Columbus, Ohio 43205, USA;</aff><aff id="af3"><label>3</label>Division of Molecular and Human Genetics, Nationwide Children's Hospital, Columbus, Ohio 43205, USA;</aff><aff id="af4"><label>4</label>Center for Cardiovascular and Pulmonary Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio 43205, USA</aff><author-notes><corresp>Corresponding authors: <email>Daniel.Koboldt@nationwidechildrens.org</email>; <email>Peter.White@nationwidechildrens.org</email></corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2018</year></pub-date><volume>4</volume><issue>3</issue><elocation-id>a002410</elocation-id><history><date date-type="received"><day>26</day><month>10</month><year>2017</year></date><date date-type="accepted"><day>26</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement><ext-link ext-link-type="uri" xlink:href="http://www.molecularcasestudies.cshlp.org/site/misc/terms.xhtml">© 2018 Koboldt et al.; Published by Cold Spring Harbor Laboratory Press</ext-link></copyright-statement><copyright-year>2018</copyright-year><license xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution-NonCommercial License</ext-link>, which permits reuse and redistribution, except for commercial purposes, provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="MCS002410Kob.pdf"/><abstract><p><SecTag type="ABS"><text><SENT sid="75776" pm="."><plain>Two sisters (ages 16 yr and 15 yr) have been followed by our clinical genetics team for several years. </plain></SENT>
<SENT sid="75777" pm="."><plain>Both girls have severe intellectual disability, hypotonia, seizures, and distinctive craniofacial features. </plain></SENT>
<SENT sid="75778" pm="."><plain>The parents are healthy and have no other children. </plain></SENT>
<SENT sid="75779" pm="."><plain>Oligo array, fragile X testing, and numerous single-gene tests were negative. </plain></SENT>
<SENT sid="75780" pm="."><plain>All four family members underwent research exome sequencing, which revealed a heterozygous nonsense mutation in ASXL3 (p.R1036X) that segregated with disease. </plain></SENT>
<SENT sid="75781" pm="."><plain>Exome data and independent Sanger sequencing confirmed that the variant is de novo, suggesting possible germline mosaicism in one parent. </plain></SENT>
<SENT sid="75782" pm="."><plain>The p.R1036X variant has never been observed in healthy human populations and has been previously reported as a pathogenic mutation. </plain></SENT>
<SENT sid="75783" pm="."><plain>Truncating de novo mutations in ASXL3 cause Bainbridge–Ropers syndrome (BRPS), a developmental disorder with similarities to Bohring–Opitz syndrome. </plain></SENT>
<SENT sid="75784" pm="."><plain>Fewer than 30 BRPS patients have been described in the literature; to our knowledge, this is the first report of the disorder in two related individuals. </plain></SENT>
<SENT sid="75785" pm="."><plain>Our findings lend further support to intellectual disability, absent speech, autistic traits, hypotonia, and distinctive facial appearance as common emerging features of Bainbridge–Ropers syndrome. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>absent speech</kwd><kwd>aplasia/hypoplasia of the corpus callosum</kwd><kwd>autism</kwd><kwd>broad nasal tip</kwd><kwd>cleft of chin</kwd><kwd>clinodactyly of the 5th finger</kwd><kwd>downslanted palpebral fissures</kwd><kwd>generalized hirsutism</kwd><kwd>high forehead</kwd><kwd>high, narrow palate</kwd><kwd>hypertelorism</kwd><kwd>incisor macrodontia</kwd><kwd>intellectual disability, severe</kwd><kwd>prominent nasal bridge</kwd><kwd>recurrent hand flapping</kwd><kwd>severe global developmental delay</kwd><kwd>severe muscular hypotonia</kwd><kwd>short stature</kwd><kwd>thick eyebrow</kwd></kwd-group></SecTag><funding-group><award-group id="funding-1"><funding-source><institution-wrap><institution>Research Institute at Nationwide Children's Hospital </institution><institution-id institution-id-type="open-funder-registry">10.13039/100011500</institution-id></institution-wrap></funding-source></award-group></funding-group><counts><page-count count="6"/></counts></article-meta></front><body><SecTag type="CASE"><sec id="s1"><title><text><SENT sid="75786" pm="."><plain>CASE PRESENTATION </plain></SENT>
</text></title><p><text><SENT sid="75787" pm="."><plain>Patient 1 is a 16-yr-old Caucasian female born at term after an uncomplicated pregnancy. </plain></SENT>
<SENT sid="75788" pm="."><plain>Her 15-yr-old sister was born at 36 weeks’ gestation by emergency cesarean section due to fetal distress. </plain></SENT>
<SENT sid="75789" pm="."><plain>Both sisters have severe intellectual disability, no language, autistic features, hypotonia, and a thin habitus. </plain></SENT>
<SENT sid="75790" pm="."><plain>They share distinctive craniofacial features including a broad/prominent forehead, hypertelorism, downslanting palpebral fissures, prominent nasal root, thick eyebrows, hirsutism, cleft chin, and strikingly prominent upper central incisors (Table 1). </plain></SENT>
<SENT sid="75791" pm="."><plain>They have a history of feeding difficulties, seizures, and developmental delay. </plain></SENT>
<SENT sid="75792" pm="."><plain>The parents were unaffected, and there was no relevant family history. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="MCS002410KOBTB1" orientation="portrait" position="float"><label>Table 1.</label><caption><p><text><SENT sid="75793" pm="."><plain>Clinical features of proband (16-yr-old female) and affected sister (15 yr old) </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"><text><SENT sid="75794" pm="."><plain>Phenotypic feature </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="75795" pm="."><plain>Patient 1 (proband) </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="75796" pm="."><plain>Patient 2 (sibling) </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><text><SENT sid="75797" pm="."><plain>Intellectual disability </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75798" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75799" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75800" pm="."><plain>Seizures </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75801" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75802" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75803" pm="."><plain>Autistic features </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75804" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75805" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75806" pm="."><plain>Global developmental delay </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75807" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75808" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75809" pm="."><plain>Language impairment </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75810" pm="."><plain>No speech </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75811" pm="."><plain>No speech </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75812" pm="."><plain>Recurrent hand flapping </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75813" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75814" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75815" pm="."><plain>Hypoplasia of corpus callosum </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75816" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75817" pm="."><plain>No </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75818" pm="."><plain>Ventriculomegaly </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75819" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75820" pm="."><plain>No </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75821" pm="."><plain>Feeding difficulties </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75822" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75823" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75824" pm="."><plain>Short stature </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75825" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75826" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75827" pm="."><plain>Face </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75828" pm="."><plain>Long </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75829" pm="."><plain>Rectangular </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75830" pm="."><plain>Forehead </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75831" pm="."><plain>Prominent </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75832" pm="."><plain>Broad </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75833" pm="."><plain>Downslanted palpebral fissures </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75834" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75835" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75836" pm="."><plain>Abnormality of the pinna </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75837" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75838" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75839" pm="."><plain>Prominent nasal bridge </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75840" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75841" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75842" pm="."><plain>Underdeveloped nasal alae </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75843" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75844" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75845" pm="."><plain>Broad nasal tip </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75846" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75847" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75848" pm="."><plain>Macrodontia of permanent maxillary central incisor </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75849" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75850" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75851" pm="."><plain>High, narrow palate </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75852" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75853" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75854" pm="."><plain>Cleft of chin </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75855" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75856" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75857" pm="."><plain>Micrognathia </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75858" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75859" pm="."><plain>Yes </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75860" pm="."><plain>Clinodactyly </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75861" pm="."><plain>Fifth finger </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75862" pm="."><plain>Fifth finger </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75863" pm="."><plain>Hirsutism </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75864" pm="."><plain>Yes </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75865" pm="."><plain>Yes </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><p><text><SENT sid="75866" pm="."><plain>The proband underwent a series of genetic tests including oligo array, fragile X, MECP2, CDKL5, SLC9A6, and COH1, all of which were negative. </plain></SENT>
<SENT sid="75867" pm="."><plain>The sibling also underwent genetic testing (ZEB2 and MECP2). </plain></SENT>
<SENT sid="75868" pm="."><plain>Both sisters had metabolic studies. </plain></SENT>
<SENT sid="75869" pm="."><plain>After these tests failed to provide a molecular diagnosis, the family underwent research exome sequencing in 2014. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec id="s2"><title><text><SENT sid="75870" pm="."><plain>TECHNICAL ANALYSIS AND METHODS </plain></SENT>
</text></title><p><text><SENT sid="75871" pm="."><plain>The proband, her affected sibling, and both parents underwent exome sequencing as follows. </plain></SENT>
<SENT sid="75872" pm="."><plain>Exome capture was performed using Agilent SureSelect v5 reagents according to manufacturer protocols. </plain></SENT>
<SENT sid="75873" pm="."><plain>Exome libraries underwent paired-end sequencing (2 × 100 bp) on an Illumina HiSeq 2500 instrument. </plain></SENT>
<SENT sid="75874" pm="."><plain>We generated ∼6.2 Gbp of uniquely mapped reads per sample (Table 2). </plain></SENT>
<SENT sid="75875" pm="."><plain>Reads were mapped to the GRCh37 reference sequence and secondary data analysis was performed using Churchill (Kelly et al. </plain></SENT>
<SENT sid="75876" pm="."><plain>2015), which implements the GATK “best practices” workflow for alignment, variant discovery and genotyping. </plain></SENT>
<SENT sid="75877" pm="."><plain>Sequencing metrics are provided in <ext-link ext-link-type="uri" xlink:href="http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a002410/-/DC1">Supplemental Table 1</ext-link>. </plain></SENT>
<SENT sid="75878" pm="."><plain>Variants were called in all four samples simultaneously, yielding 612,356 variants of which 574,390 (506,121 single nucleotide variants and 68,269 indels) passed minimum quality filters (QUAL &gt; 100). </plain></SENT>
<SENT sid="75879" pm="."><plain>Family relatedness was confirmed using the KING algorithm (v2.0; see <ext-link ext-link-type="uri" xlink:href="http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a002410/-/DC1">Supplemental Table 2</ext-link>; Manichaikul et al. </plain></SENT>
<SENT sid="75880" pm="."><plain>2010). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="MCS002410KOBTB2" orientation="portrait" position="float"><label>Table 2.</label><caption><p><text><SENT sid="75881" pm="."><plain>Exome sequencing metrics for the proband, sibling, and parents described in this study </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"><text><SENT sid="75882" pm="."><plain>Sample </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="75883" pm="."><plain>Reads </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="75884" pm="."><plain>Mapped </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="75885" pm="."><plain>Duplicate </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="75886" pm="."><plain>Map rate (%) </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="75887" pm="."><plain>Dup. rate </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="75888" pm="."><plain>Avg. depth </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><text><SENT sid="75889" pm="."><plain>Proband </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75890" pm="."><plain>56,019,520 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75891" pm="."><plain>55,815,413 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75892" pm="."><plain>1,577,081 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75893" pm="."><plain>99.64 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75894" pm="."><plain>2.83% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75895" pm="."><plain>55.0 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75896" pm="."><plain>Mother </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75897" pm="."><plain>66,027,995 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75898" pm="."><plain>65,781,485 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75899" pm="."><plain>3,173,546 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75900" pm="."><plain>99.63 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75901" pm="."><plain>4.82% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75902" pm="."><plain>64.3 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75903" pm="."><plain>Father </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75904" pm="."><plain>69,163,438 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75905" pm="."><plain>68,854,038 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75906" pm="."><plain>3,044,286 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75907" pm="."><plain>99.55 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75908" pm="."><plain>4.42% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75909" pm="."><plain>65.4 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="75910" pm="."><plain>Sibling </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75911" pm="."><plain>63,049,513 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75912" pm="."><plain>62,811,744 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75913" pm="."><plain>2,033,149 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75914" pm="."><plain>99.62 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75915" pm="."><plain>3.24% </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75916" pm="."><plain>62.3 </plain></SENT>
</text></td></tr></tbody></table></table-wrap></SecTag><p><text><SENT sid="75917" pm="."><plain>SNPeff, ANNOVAR, and custom in-house scripts were used to annotate SNPs/indels with gene, transcript, function class, damaging scores, and population allele frequencies. </plain></SENT>
<SENT sid="75918" pm="."><plain>Some 32,095 variants mapped to the exons or splice regions of known protein-coding genes. </plain></SENT>
<SENT sid="75919" pm="."><plain>After removing common variants (MAF &gt; 0.01 in the ExAC, ESP, or 1000 Genomes databases), we selected for further analysis all splice site, frameshift, and nonsense variants, as well as missense variants predicted to be damaging by SIFT (score &lt; 0.05), PolyPhen (score &gt; 0.453), GERP (score &gt; 2.0), or CADD (Phred score &gt; 15). </plain></SENT>
</text></p><p><text><SENT sid="75920" pm="."><plain>We searched for variants consistent with recessive inheritance that were present in both patients, finding no compound-heterozygous variants but two homozygous recessive variants of uncertain significance (described in the <ext-link ext-link-type="uri" xlink:href="http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a002410/-/DC1">Supplemental Text</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a002410/-/DC1">Supplemental Table 3</ext-link>). </plain></SENT>
<SENT sid="75921" pm="."><plain>We also searched for candidate de novo mutations and identified a candidate nonsense mutation at the same position in both patients. </plain></SENT>
</text></p></sec></SecTag><sec id="s3"><title><text><SENT sid="75922" pm="."><plain>VARIANT INTERPRETATION </plain></SENT>
</text></title><p><text><SENT sid="75923" pm="."><plain>A heterozygous nonsense variant in ASXL3 (Table 3) was present in both sisters but absent from the parents. </plain></SENT>
<SENT sid="75924" pm="."><plain>Manual review of the exome data verified the variant in both patients but showed no evidence of the alternate allele in either parent (<ext-link ext-link-type="uri" xlink:href="http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a002410/-/DC1">Supplemental Fig. 1</ext-link>). </plain></SENT>
<SENT sid="75925" pm="."><plain>The de novo status was independently confirmed by Sanger sequencing of all four individuals (<ext-link ext-link-type="uri" xlink:href="http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a002410/-/DC1">Supplemental Fig. 2</ext-link>). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="MCS002410KOBTB3" orientation="portrait" position="float"><label>Table 3.</label><caption><p><text><SENT sid="75926" pm="."><plain>Genomic findings and variant interpretation </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"><text><SENT sid="75927" pm="."><plain>Gene </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="75928" pm="."><plain>Genomic location </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="75929" pm="."><plain>HGVS cDNA </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="75930" pm="."><plain>HGVS protein </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="75931" pm="."><plain>Zygosity (pro/sib) </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="75932" pm="."><plain>Parent of origin </plain></SENT>
</text></th><th align="center" rowspan="1" colspan="1"><text><SENT sid="75933" pm="."><plain>Interpretation </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><text><SENT sid="75934" pm="."><plain>ASXL3 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75935" pm="."><plain>Chr 18:31322918  C&gt;T (GRCh37) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75936" pm="."><plain>NM_030632.1:  c.3106C&gt;T </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75937" pm="."><plain>p.R1036X </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75938" pm="."><plain>Het/Het </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75939" pm="."><plain>De novo </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75940" pm="."><plain>Pathogenic (PVS1,  PS2, PM2, PP1,  PP5) </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn><p><text><SENT sid="75941" pm="."><plain>Criteria: PVS1, null variant; PS2, de novo in a patient with disease and no family history; PM2, absent from population controls; PP1, cosegregation with disease in a gene definitively known to cause the disease; PP5, reputable source recently reports the variant as pathogenic, but evidence was not available for us to perform an independent evaluation. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="75942" pm="."><plain>The variant is predicted to cause a stop-gain at amino acid 1036 (NM_030632.1 c.3106C&gt;T, p.R1036X), at ∼46% of its wild-type length (Fig. 1A). </plain></SENT>
<SENT sid="75943" pm="."><plain>It has never been observed in 122,882 individuals in the gnomAD database, making it extremely rare in human populations. </plain></SENT>
<SENT sid="75944" pm="."><plain>However, truncating mutations in ASXL3 were recently reported as the cause of Bainbridge–Ropers syndrome (BRPS, OMIM #615485), a disorder similar to Bohring–Opitz syndrome, which is caused by truncating mutations in ASXL1 (Bainbridge et al. </plain></SENT>
<SENT sid="75945" pm="."><plain>2013). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="MCS002410KOBF1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p><text><SENT sid="75946" pm="."><plain>Graphical view of disease-causing mutations. </plain></SENT>
<SENT sid="75947" pm="."><plain>(A) The de novo nonsense mutation in ASXL3 detected in the proband. </plain></SENT>
<SENT sid="75948" pm="."><plain>(B) Pathogenic mutations in ASXL3 reported to the HGMD Pro database. </plain></SENT>
<SENT sid="75949" pm="."><plain>(C) Pathogenic and Likely Pathogenic nonsense/frameshift variants in ASXL3 reported in ClinVar as of November 2017. </plain></SENT>
<SENT sid="75950" pm="."><plain>(D) Pathogenic mutations in ASXL1 in Bohring–Opitz syndrome patients as reported to the HGMD Pro database. </plain></SENT>
<SENT sid="75951" pm="."><plain>(E) Constraint metrics for ASXL3 from the ExAC database. </plain></SENT>
</text></p></caption><graphic xlink:href="MCS002410Kob_F1"/></fig></SecTag><p><text><SENT sid="75952" pm="."><plain>The Human Gene Mutation Database (HGMD) contains 10 nonsense/frameshift ASXL3 variants (five nonsense variants and five frameshift indels) reported in patients with Bainbridge–Ropers syndrome or Bohring–Opitz-like syndrome (Fig. 1B). </plain></SENT>
<SENT sid="75953" pm="."><plain>The ClinVar database contains 22 nonsense/frameshift variants (12 nonsense variants including p.R1036X, and 10 frameshift indels), all of which are reported as Pathogenic or Likely Pathogenic (Fig. 1C). </plain></SENT>
<SENT sid="75954" pm="."><plain>Of note, many of the pathogenic mutations reported in ASXL1 in Bohring–Opitz syndrome also truncate ∼50% of the encoded protein (Fig. 1D). </plain></SENT>
<SENT sid="75955" pm="."><plain>Constraint metrics from the ExAC database (Lek et al. </plain></SENT>
<SENT sid="75956" pm="."><plain>2016) likewise indicate that ASXL3 is extremely intolerant of loss-of-function (LoF) mutations (43.1 variants expected, 3 observed, pLI = 1.00; Fig. 1E). </plain></SENT>
</text></p><p><text><SENT sid="75957" pm="."><plain>In summary, this de novo nonsense mutation is present in both affected individuals, absent from databases of population controls, and consistent with previously reported pathogenic mutations in ASXL3. </plain></SENT>
<SENT sid="75958" pm="."><plain>We therefore conclude that it is pathogenic, and we provide a molecular diagnosis of Bainbridge–Ropers syndrome to the proband and her affected sibling. </plain></SENT>
</text></p></sec><SecTag type="CONCL"><sec id="s4"><title><text><SENT sid="75959" pm="."><plain>SUMMARY </plain></SENT>
</text></title><p><text><SENT sid="75960" pm="."><plain>Bainbridge–Ropers syndrome (BRPS) was first described in 2013, when Bainbridge et al. reported de novo truncating mutations in four unrelated probands with feeding difficulties, failure to thrive, neurological abnormalities, and significant developmental delay. </plain></SENT>
<SENT sid="75961" pm="."><plain>To date, fewer than 30 cases of BRPS have been described in the literature (Bainbridge et al. </plain></SENT>
<SENT sid="75962" pm="."><plain>2013; Dinwiddie et al. </plain></SENT>
<SENT sid="75963" pm="."><plain>2013; Srivastava et al. </plain></SENT>
<SENT sid="75964" pm="."><plain>2016; Balasubramanian et al. </plain></SENT>
<SENT sid="75965" pm="."><plain>2017; Kuechler et al. </plain></SENT>
<SENT sid="75966" pm="."><plain>2017). </plain></SENT>
<SENT sid="75967" pm="."><plain>The report by Kuechler et al. includes a 4-yr old female with the p.R1036X mutation. </plain></SENT>
<SENT sid="75968" pm="."><plain>She was not reported to have seizures (<ext-link ext-link-type="uri" xlink:href="http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a002410/-/DC1">Supplemental Table 4</ext-link>), but she and both of our patients share the six most emerging hallmarks of BRPS: severe intellectual disability, poor/absent speech, autistic traits, distinct face, hypotonia, and significant feeding difficulties. </plain></SENT>
<SENT sid="75969" pm="."><plain>We assess our patients for the clinical features highlighted by Balasubramanian et al. (2017) in <ext-link ext-link-type="uri" xlink:href="http://www.molecularcasestudies.org/lookup/suppl/doi:10.1101/mcs.a002410/-/DC1">Supplemental Table 5</ext-link>. </plain></SENT>
</text></p><p><text><SENT sid="75970" pm="."><plain>We recently diagnosed a third (unrelated) child at our institution, suggesting that the prevalence of BRPS is likely to be higher than currently reported in the medical literature, and the diagnosis will be made more frequently as WES is incorporated more routinely into clinical practice. </plain></SENT>
<SENT sid="75971" pm="."><plain>Indeed, the membership of a support group for BRPS families suggests that as many as 200 patients may have been diagnosed to date (M Bainbridge, pers. comm.). </plain></SENT>
</text></p><p><text><SENT sid="75972" pm="."><plain>To our knowledge, this is the first report of BRPS caused by the same de novo mutation in two related individuals (siblings). </plain></SENT>
<SENT sid="75973" pm="."><plain>Although it is theoretically possible that the same mutation arose independently in two different embryos, germline mosaicism in one of the parents seems a more likely explanation. </plain></SENT>
<SENT sid="75974" pm="."><plain>The family declined further testing to confirm the origin of the mutation. </plain></SENT>
</text></p></sec></SecTag><sec id="s5"><title><text><SENT sid="75975" pm="."><plain>ADDITIONAL INFORMATION </plain></SENT>
</text></title><sec id="s5a"><title><text><SENT sid="75976" pm="."><plain>Data Deposition and Access </plain></SENT>
</text></title><p><text><SENT sid="75977" pm="."><plain>The ASXL3 variant and information about its interpretation were submitted to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/) on September 29, 2017 (SCV000605939) and accepted/released on October 9, 2017. </plain></SENT>
<SENT sid="75978" pm="."><plain>Unfortunately, the informed consent does not allow for deposition of the raw sequencing data into public databases. </plain></SENT>
</text></p></sec><sec id="s5b"><title><text><SENT sid="75979" pm="."><plain>Ethics Statement </plain></SENT>
</text></title><p><text><SENT sid="75980" pm="."><plain>Written consent was obtained prior to enrolling subjects into a research protocol approved by the Institutional Review Board at Nationwide Children's Hospital (IRB11-00215 Study: Using Genome Sequencing to Identify Causes of Rare Birth Defects and Rare Disorders). </plain></SENT>
</text></p></sec><sec id="s5c"><title><text><SENT sid="75981" pm="."><plain>Acknowledgments </plain></SENT>
</text></title><p><text><SENT sid="75982" pm="."><plain>We thank the patients and their family for participation in research. </plain></SENT>
<SENT sid="75983" pm="."><plain>We also thank Matthew Bainbridge for discussions about the BRPS patient population. </plain></SENT>
</text></p></sec><sec id="s5d"><title><text><SENT sid="75984" pm="."><plain>Author Contributions </plain></SENT>
</text></title><p><text><SENT sid="75985" pm="."><plain>D.C.K. contributed to genomic analysis, variant interpretation, and manuscript preparation. </plain></SENT>
<SENT sid="75986" pm="."><plain>T.M.M. contributed to patient enrollment and phenotyping. </plain></SENT>
<SENT sid="75987" pm="."><plain>B.J.K. contributed to genomic analysis and variant interpretation. </plain></SENT>
<SENT sid="75988" pm="."><plain>P.W. and R.K.W. contributed to project supervision and manuscript preparation. </plain></SENT>
<SENT sid="75989" pm="."><plain>K.M., E.S., D.B., and S.E.H. contributed to patient phenotyping and variant interpretation. </plain></SENT>
<SENT sid="75990" pm="."><plain>All authors contributed to final manuscript review. </plain></SENT>
</text></p></sec><sec id="s5e"><title><text><SENT sid="75991" pm="."><plain>Funding </plain></SENT>
</text></title><p><text><SENT sid="75992" pm="."><plain>This work was supported by The Research Institute at Nationwide Children's Hospital. </plain></SENT>
</text></p></sec><sec id="s5f"><title><text><SENT sid="75993" pm="."><plain>Competing Interest Statement </plain></SENT>
</text></title><p><text><SENT sid="75994" pm="."><plain>The authors have declared no competing interest. </plain></SENT>
</text></p></sec><sec id="s5g"><title><text><SENT sid="75995" pm="."><plain>Referees </plain></SENT>
</text></title><p><text><SENT sid="75996" pm="."><plain>Darrell L. </plain></SENT>
<SENT sid="75997" pm="."><plain>Dinwiddie </plain></SENT>
</text></p><p><text><SENT sid="75998" pm="."><plain>Anshika Srivastava </plain></SENT>
</text></p><p><text><SENT sid="75999" pm="."><plain>Anonymous </plain></SENT>
</text></p></sec></sec>
<SecTag type="SUPPL"><sec sec-type="supplementary-material">
<title><text><SENT sid="76000" pm="."><plain>Supplementary Material </plain></SENT>
</text></title>
<supplementary-material id="PMC_1" content-type="local-data">
<caption>
<title><text><SENT sid="76001" pm="."><plain>Supplemental Material </plain></SENT>
</text></title>
</caption>
<media mimetype="text" mime-subtype="html" xlink:href="supp_4_3_a002410__index.html"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="msword" xlink:href="supp_mcs.a002410_Supplemental_Material.docx"/>
<media xlink:role="associated-file" mimetype="application" mime-subtype="vnd.ms-excel" xlink:href="supp_mcs.a002410_Supplemental_Table_5.xlsx"/>
</supplementary-material>
</sec></SecTag>
</body><back><fn-group><SecTag type="SUPPL"><fn fn-type="supplementary-material"><p><text><SENT sid="76002" pm="."><plain>[Supplemental material is available for this article.] </plain></SENT>
</text></p></fn></SecTag></fn-group><SecTag type="REF"><ref-list><title>REFERENCES</title><ref id="MCS002410KOBC1"><text><SENT sid="76003" pm="."><plain>BainbridgeMN, HuH, MuznyDM, MusanteL, LupskiJR, GrahamBH, ChenW, GrippKW, JennyK, WienkerTF,  2013 De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring–Opitz syndrome. Genome Med 5: 11.23383720 </plain></SENT>
</text></ref><ref id="MCS002410KOBC2"><text><SENT sid="76004" pm="."><plain>BalasubramanianM, WilloughbyJ, FryAE, WeberA, FirthHV, DeshpandeC, BergJN, ChandlerK, MetcalfeKA, LamW,  2017 Delineating the phenotypic spectrum of Bainbridge–Ropers syndrome: 12 new patients with de novo, heterozygous, loss-of-function mutations in ASXL3 and review of published literature. J Med Genet 54: 537–543.28100473 </plain></SENT>
</text></ref><ref id="MCS002410KOBC3"><text><SENT sid="76005" pm="."><plain>DinwiddieDL, SodenSE, SaundersCJ, MillerNA, FarrowEG, SmithLD, KingsmoreSF. 2013 De novo frameshift mutation in ASXL3 in a patient with global developmental delay, microcephaly, and craniofacial anomalies. BMC Med Genomics 6: 32.24044690 </plain></SENT>
</text></ref><ref id="MCS002410KOBC4"><text><SENT sid="76006" pm="."><plain>KellyBJ, FitchJR, HuY, CorsmeierDJ, ZhongH, WetzelAN, NordquistRD, NewsomDL, WhiteP. 2015 Churchill: an ultra-fast, deterministic, highly scalable and balanced parallelization strategy for the discovery of human genetic variation in clinical and population-scale genomics. Genome Biol 16: 6.25600152 </plain></SENT>
</text></ref><ref id="MCS002410KOBC5"><text><SENT sid="76007" pm="."><plain>KuechlerA, CzeschikJC, GrafE, GrasshoffU, HüffmeierU, BusaT, Beck-WoedlS, FaivreL, RivièreJB, BaderI,  2017 Bainbridge–Ropers syndrome caused by loss-of-function variants in ASXL3: a recognizable condition. Eur J Hum Genet 25: 183–191.27901041 </plain></SENT>
</text></ref><ref id="MCS002410KOBC6"><text><SENT sid="76008" pm="."><plain>LekM, KarczewskiKJ, MinikelEV, SamochaKE, BanksE, FennellT, O'Donnell-LuriaAH, WareJS, HillAJ, CummingsBB,  2016 Analysis of protein-coding genetic variation in 60,706 humans. Nature 536: 285–291.27535533 </plain></SENT>
</text></ref><ref id="MCS002410KOBC7"><text><SENT sid="76009" pm="."><plain>ManichaikulA, MychaleckyjJC, RichSS, DalyK, SaleM, ChenWM. 2010 Robust relationship inference in genome-wide association studies. Bioinformatics 26: 2867–2873.20926424 </plain></SENT>
</text></ref><ref id="MCS002410KOBC8"><text><SENT sid="76010" pm="."><plain>SrivastavaA, RiteshKC, TsanYC, LiaoR, SuF, CaoX, HannibalMC, KeeganCE, ChinnaiyanAM, MartinDM,  2016 De novo dominant ASXL3 mutations alter H2A deubiquitination and transcription in Bainbridge–Ropers syndrome. Hum Mol Genet 25: 597–608.26647312 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
